Literature DB >> 17705507

Cytotoxic ribonucleases: the dichotomy of Coulombic forces.

R Jeremy Johnson1, Tzu-Yuan Chao, Luke D Lavis, Ronald T Raines.   

Abstract

Cells tightly regulate their contents. Still, nonspecific Coulombic interactions between cationic molecules and anionic membrane components can lead to adventitious endocytosis. Here, we characterize this process in a natural system. To do so, we create variants of human pancreatic ribonuclease (RNase 1) that differ in net molecular charge. By conjugating a small-molecule latent fluorophore to these variants and using flow cytometry, we are able to determine the kinetic mechanism for RNase 1 internalization into live human cells. We find that internalization increases with solution concentration and is not saturable. Internalization also increases with time to a steady-state level, which varies linearly with molecular charge. In contrast, the rate constant for internalization (t1/2 = 2 h) is independent of charge. We conclude that internalization involves an extracellular equilibrium complex between the cationic proteins and abundant anionic cell-surface molecules, followed by rate-limiting internalization. The enhanced internalization of more cationic variants of RNase 1 is, however, countered by their increased affinity for the cytosolic ribonuclease inhibitor protein, which is anionic. Thus, Coulombic forces mediate extracellular and intracellular equilibria in a dichotomous manner that both endangers cells and defends them from the potentially lethal enzymatic activity of ribonucleases.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17705507      PMCID: PMC2864629          DOI: 10.1021/bi700857u

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  52 in total

1.  Ribonuclease A.

Authors:  Ronald T. Raines
Journal:  Chem Rev       Date:  1998-05-07       Impact factor: 60.622

2.  Studies on the internalization mechanism of cationic cell-penetrating peptides.

Authors:  Guillaume Drin; Sylvine Cottin; Emmanuelle Blanc; Anthony R Rees; Jamal Temsamani
Journal:  J Biol Chem       Date:  2003-06-03       Impact factor: 5.157

Review 3.  Ribonuclease inhibitor: structure and function.

Authors:  Kimberly A Dickson; Marcia C Haigis; Ronald T Raines
Journal:  Prog Nucleic Acid Res Mol Biol       Date:  2005

Review 4.  Endocytosis conducts the cell signaling orchestra.

Authors:  Simona Polo; Pier Paolo Di Fiore
Journal:  Cell       Date:  2006-03-10       Impact factor: 41.582

5.  Cellular electrophoretic mobility data: a first approach to a database.

Authors:  G G Slivinsky; W C Hymer; J Bauer; D R Morrison
Journal:  Electrophoresis       Date:  1997-06       Impact factor: 3.535

6.  Preparation of potent cytotoxic ribonucleases by cationization: enhanced cellular uptake and decreased interaction with ribonuclease inhibitor by chemical modification of carboxyl groups.

Authors:  J Futami; T Maeda; M Kitazoe; E Nukui; H Tada; M Seno; M Kosaka; H Yamada
Journal:  Biochemistry       Date:  2001-06-26       Impact factor: 3.162

7.  Cationic TAT peptide transduction domain enters cells by macropinocytosis.

Authors:  Ian M Kaplan; Jehangir S Wadia; Steven F Dowdy
Journal:  J Control Release       Date:  2005-01-20       Impact factor: 9.776

8.  Reassessment of Ellman's reagent.

Authors:  P W Riddles; R L Blakeley; B Zerner
Journal:  Methods Enzymol       Date:  1983       Impact factor: 1.600

Review 9.  Clinical aspects of altered glycosylation of glycoproteins in cancer.

Authors:  T F Orntoft; E M Vestergaard
Journal:  Electrophoresis       Date:  1999-02       Impact factor: 3.535

10.  Comparison of RNases and toxins upon injection into Xenopus oocytes.

Authors:  S K Saxena; S M Rybak; G Winkler; H M Meade; P McGray; R J Youle; E J Ackerman
Journal:  J Biol Chem       Date:  1991-11-05       Impact factor: 5.157

View more
  29 in total

1.  Site-specific PEGylation endows a mammalian ribonuclease with antitumor activity.

Authors:  Thomas J Rutkoski; John A Kink; Laura E Strong; Ronald T Raines
Journal:  Cancer Biol Ther       Date:  2011-08-01       Impact factor: 4.742

2.  Interaction of nucleic acids with the glycocalyx.

Authors:  Michael J Palte; Ronald T Raines
Journal:  J Am Chem Soc       Date:  2012-03-29       Impact factor: 15.419

3.  A highly sensitive fluorogenic probe for cytochrome P450 activity in live cells.

Authors:  Melissa M Yatzeck; Luke D Lavis; Tzu-Yuan Chao; Sunil S Chandran; Ronald T Raines
Journal:  Bioorg Med Chem Lett       Date:  2008-06-10       Impact factor: 2.823

4.  Mechanism of ribonuclease A endocytosis: analogies to cell-penetrating peptides.

Authors:  Tzu-Yuan Chao; Ronald T Raines
Journal:  Biochemistry       Date:  2011-09-07       Impact factor: 3.162

5.  Esterification Delivers a Functional Enzyme into a Human Cell.

Authors:  Valerie T Ressler; Kalie A Mix; Ronald T Raines
Journal:  ACS Chem Biol       Date:  2019-03-11       Impact factor: 5.100

6.  Fine-Tuning Strain and Electronic Activation of Strain-Promoted 1,3-Dipolar Cycloadditions with Endocyclic Sulfamates in SNO-OCTs.

Authors:  Eileen G Burke; Brian Gold; Trish T Hoang; Ronald T Raines; Jennifer M Schomaker
Journal:  J Am Chem Soc       Date:  2017-05-31       Impact factor: 15.419

7.  Arginine residues are more effective than lysine residues in eliciting the cellular uptake of onconase.

Authors:  Nadia K Sundlass; Ronald T Raines
Journal:  Biochemistry       Date:  2011-11-04       Impact factor: 3.162

8.  Intraspecies regulation of ribonucleolytic activity.

Authors:  R Jeremy Johnson; Luke D Lavis; Ronald T Raines
Journal:  Biochemistry       Date:  2007-10-23       Impact factor: 3.162

Review 9.  Evasion of ribonuclease inhibitor as a determinant of ribonuclease cytotoxicity.

Authors:  Thomas J Rutkoski; Ronald T Raines
Journal:  Curr Pharm Biotechnol       Date:  2008-06       Impact factor: 2.837

Review 10.  Onconase and amphinase, the antitumor ribonucleases from Rana pipiens oocytes.

Authors:  W Ardelt; K Shogen; Z Darzynkiewicz
Journal:  Curr Pharm Biotechnol       Date:  2008-06       Impact factor: 2.837

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.